STING1 and neoplasm: These findings suggest that tumor cell-intrinsic STING signaling contributes to creating an immune-active, cytotoxic T cell-enriched TME through mechanisms involving the type I IFN response and the CXCL10–CXCR3 axis in dMMR tumors.